The original instrument and the following digest, which constitutes no part of the
legislative instrument, were prepared by Christopher D. Adams.
DIGEST
Heitmeier (SB 496)
Present law provides no prescription for a Schedule II substance may be refilled.
Proposed law provides a Schedule II prescription may not be filled more than 90 days after the
date of the prescription.
Proposed law provides a pharmacist shall not dispense any Schedule II controlled dangerous
substance upon a prescription of a prescriber who is not licensed by the state of Louisiana.
Proposed law provides a prescriber shall access the Prescription Monitoring Program prior to
initially prescribing any Schedule II controlled dangerous substance to a patient for the treatment
of non-cancer-related chronic or intractable pain.
Effective upon signature of the governor or lapse of time for gubernatorial action.
(Amends R.S. 40:978(A); adds R.S. 40:978(E) and (F))
Summary of Amendments Adopted by Senate
Committee Amendments Proposed by Senate Committee on Health and Welfare to the
original bill
1. Deletes the provisions prohibiting prescription for any controlled substance being
issued for more than 120 dosage units or a 30-day supply of the maximum total
daily dosage and the provision prohibiting more than three controlled substance
prescriptions issued for a patient by a licensed practitioner during the same 30-day
period.
2. Provides a pharmacist not dispense any Schedule II controlled dangerous
substance upon a prescription of a prescriber who is not licensed by the state of
Louisiana and a prescriber access the Prescription Monitoring Program prior to
initially prescribing any Schedule II controlled dangerous substance to a patient
for the treatment of non-cancer-related chronic or intractable pain.